Smart glasses have burst onto the scene in some high-profile places — but they’re still a rare sight on the faces of regular ...

Oil futures settled lower to post a third-straight weekly loss on Friday, but moved up in extended trading after the U.S.

SpaceX’s latest point of pride is its pivot toward becoming a provider of artificial-intelligence compute. But this new twist comes with its own slew of risks. Over the last two ...

Fewer people are working from home — and that’s probably a good thing. In fact, new research suggests they might be happier and more successful if they go back to the office.

The equal-weighted version of the S&P 500 outperformed its traditional capitalization-weighted sibling this week by the ...

Oracle’s stock missed out on the broader software rally, as the company is tied to OpenAI’s success through its cloud-infrastructure business.

As Cape Verde faces off against Saudi Arabia tonight, here’s a look at what could be next for the breakout World Cup star.

Dear Quentin, I read your article about Social Security (“Take the money while you can. I’m a CPA and tell my clients to take ...

Despite Micron’s stellar sales and earnings growth, the stock trades at a forward price/earnings valuation that is less than ...

Universe Pharmaceuticals agreed to acquire Best Praise International Limited in an all-stock deal valued at $10.8 million. Universe will pay for the acquisition with about 4.8 million shares of its ...

Why home loan yields don’t wait around for the central bank to make a move, and how to know if it’s finally time to refinance ...

Lantheus Holdings's new drug application was rejected by the Food and Drug Administration's due to unresolved manufacturing issues at a third-party facility. The application was for LNTH-2501, an ...